Dalus Capital

Dalus Capital is a Monterrey-based VC writing Series A and Series B checks in the $1M to $5M range, focused on scalable technology businesses addressing Latin America’s largest challenges. The firm has signaled interest in digital health, AI/ML applied to healthcare, and consumer wellness, and its Monterrey headquarters reflects a posture that takes the industrial and commercial realities of northern Mexico seriously rather than viewing the country through a Mexico City lens alone. Geographic focus is Mexico-anchored with broader Latin American expansion, and the firm benefits from proximity to the US border and to the strategic flows of capital, talent, and trade that animate the Monterrey corporate ecosystem. The right founder profile is a Series A-ready CEO running a tech-enabled healthcare or wellness business with proven Mexican commercial traction and a credible regional expansion thesis, ideally with a model that benefits from cross-border integration with US payers, providers, or consumers. The wrong fit is a research-stage biotech or a deep-science platform; Dalus is a tech-enabled growth investor rather than a science specialist. The right entry path is through Monterrey and Mexico City founder networks, through co-investors at firms like ALLVP, Cometa, and Mountain Nazca, and through warm introductions from operators in the existing portfolio. The firm is also reachable through industrial and corporate ecosystem connections in Monterrey, which is a meaningfully different sourcing channel from the consumer-internet networks that dominate Mexico City venture activity. When pitching, lead with the unit economics specific to the Mexican market, the regulatory and payer dynamics that affect your model, and the AI capability that materially improves your cost-to-serve or clinical outcome rather than serving as a marketing veneer. Then connect to the regional expansion logic. Caveats: Dalus is a regionally credible mid-market firm rather than a global tier-one brand, so founders should expect strong local diligence but should plan to bring in international Series B and growth-stage investors when the metrics warrant it. Use Dalus when you need a Mexican investor with northern industrial sensibilities, deep regional networks, and the willingness to underwrite genuine technology bets in Latin American healthcare.